Head and Shoulders ® Clinical Solutions Leave-On Dandruff Treatment

Head and Shoulders Clinical Solutions Leave-On Dandruff Treatment by

Drug Labeling and Warnings

Head and Shoulders Clinical Solutions Leave-On Dandruff Treatment by is a Otc medication manufactured, distributed, or labeled by The Procter & Gamble Manufacturing Company. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

HEAD AND SHOULDERS CLINICAL SOLUTIONS LEAVE-ON DANDRUFF TREATMENT- pyrithione zinc liquid 
The Procter & Gamble Manufacturing Company

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Head and Shoulders ®
Clinical Solutions Leave-On Dandruff Treatment

Drug Facts

Active ingredient

Pyrithione zinc 0.1%

Purpose

Anti-dandruff

Use

helps prevent recurrence of flaking and itching associated with dandruff.

Warnings

FLAMMABLE. DO NOT USE NEAR FLAME OR WHILE SMOKING. USE ONLY IN
VENTILATED AREAS.

For external use only.

When using this product

  • avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

  • condition worsens or does not improve after regular use of this product as directed.

Keep this and all drugs out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

entire scalp.

  • apply to affected areas one to four times daily or as directed by a doctor.
  • place package tip close to scalp on damp or dry hair and use 15 sprays to cover the

Inactive ingredients

Alcohol denat., water/eau, niacinamide, caffeine, BIS-PEG/PPG-16/16 PEG/PPG-16/16 dimethicone, glycerin, fragrance/parfum, acrylates/C10-30 alkyl acrylate crosspolymer, panthenol, tetrahydroxypropyl ethylenediamine.

Questions (or comments)?

1-800-723-9569

Dist. by PROCTER & GAMBLE,
CINCINNATI, OH 45202

PRINCIPAL DISPLAY PANEL - 125 mL Bottle Label

head &

shoulders ®


CLINICAL

SOLUTIONS



pyrithione zinc

dandruff treatment

LEAVE-ON DANDRUFF TREATMENT

24hr Protection

Dandruff * Itch * Irritation

CLINICALLY PROVEN


125 mL (4.2 FL OZ)
HS1

HEAD AND SHOULDERS CLINICAL SOLUTIONS LEAVE-ON DANDRUFF TREATMENT 
pyrithione zinc liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 69423-152
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5) PYRITHIONE ZINC0.1 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
ALCOHOL (UNII: 3K9958V90M)  
NIACINAMIDE (UNII: 25X51I8RD4)  
GLYCERIN (UNII: PDC6A3C0OX)  
CAFFEINE (UNII: 3G6A5W338E)  
BIS-PEG/PPG-16/16 PEG/PPG-16/16 DIMETHICONE (UNII: 55A74AJ3KB)  
PANTHENOL (UNII: WV9CM0O67Z)  
EDETOL (UNII: Q4R969U9FR)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 69423-152-5050 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product11/17/201601/15/2019
2NDC: 69423-152-12125 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product11/17/201602/01/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart358H11/17/201602/01/2020
Labeler - The Procter & Gamble Manufacturing Company (004238200)

Revised: 1/2020
 
The Pr

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.